Franklin Resources
GTHX

Franklin Resources’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Franklin Resources’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,556
Closed -$222K – 2566
2021
Q3 		$222K Buy
+16,556
New +$270K ﹤0.01% 2198
2019
Q4 		– Sell
-1,185,958
Closed -$27M – 1586
2019
Q3 		$27M Sell
1,185,958
-48,400
-4% -$1.53M 0.01% 677
2019
Q2 		$37.8M Sell
1,234,358
-300
-0% -$6.32K 0.02% 616
2019
Q1 		$20.5M Sell
1,234,658
-200
-0% -$3.79K 0.01% 738
2018
Q4 		$23.6M Buy
1,234,858
+70,900
+6% +$2.66M 0.01% 659
2018
Q3 		$60.9M Sell
1,163,958
-115,010
-9% -$6.27M 0.03% 491
2018
Q2 		$55.6M Sell
1,278,968
-28,948
-2% -$1.24M 0.03% 504
2018
Q1 		$48.5M Sell
1,307,916
-227,700
-15% -$6.08M 0.02% 545
2017
Q4 		$30.5M Buy
1,535,616
+141,000
+10% +$3.03M 0.01% 686
2017
Q3 		$33.9M Buy
1,394,616
+783,916
+128% +$14.5M 0.02% 648
2017
Q2 		$10.7M Buy
+610,700
New +$10.7M 0.01% 935

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Franklin Resources's GTHX Position: Q4 2021 in Review

Franklin Resources sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2021, closing a stake of 16,556 shares — an estimated $222K sold.

Franklin Resources first reported a position in GTHX in Q2 2017 and held it in 11 quarters. The position peaked at $60.9M in Q3 2018. 108 funds tracked by Wall St. Rank hold GTHX as of Q4 2021.

  • Franklin Resources reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Franklin Resources sold 16,556 G1 Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $222K.
  • Franklin Resources first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 11 quarters.
  • Franklin Resources's G1 Therapeutics, Inc. Common Stock position peaked at $60.9M in Q3 2018.
  • 108 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Franklin Resources's 13F filing for Q4 2021, filed 11 Feb 2022.